BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 11821008)

  • 101. Adrenergic mechanisms and blood-brain barrier permeability.
    Sarmento A; Borges N; Azevedo I
    Crit Care Med; 2005 Jun; 33(6):1474. PubMed ID: 15942411
    [No Abstract]   [Full Text] [Related]  

  • 102. The effect of cellular microenvironment on vessels in the brain. Part 1: Vessel structure in tumour, peritumour and brain from humans with malignant glioma.
    Stewart PA; Farrell CL; Del Maestro RF
    Int J Radiat Biol; 1991; 60(1-2):125-30. PubMed ID: 1677960
    [No Abstract]   [Full Text] [Related]  

  • 103. [Paraneoplastic edema syndromes in acute myelomonocytic leukemia: role of TNF-alpha and IL-6?].
    Sotto A; Richard B; Assens C; Porneuf M; Bes G; Jourdan J
    Rev Med Interne; 1994; 15(10):673-5. PubMed ID: 7800989
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Cerebral pericytes--a second line of defense in controlling blood-brain barrier peptide metabolism.
    Krause D; Kunz J; Dermietzel R
    Adv Exp Med Biol; 1993; 331():149-52. PubMed ID: 8101424
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Isovolemic hemodilution with dextran prevents contrast medium induced impairment of pancreatic microcirculation.
    Zikria BA; Bascom J
    Am J Surg; 1997 May; 173(5):458. PubMed ID: 9168095
    [No Abstract]   [Full Text] [Related]  

  • 106. Investigation of the blood brain barrier permeability in experimental P avitaminosis.
    Vãrkonyi T; Antal A; Gãbor M; Benkö S
    Experientia; 1971 Aug; 27(8):936-7. PubMed ID: 5147268
    [No Abstract]   [Full Text] [Related]  

  • 107. Tumor Necrosis Factor and Drug Delivery in the Blood-Brain Barrier.
    Albensi BC
    Drug News Perspect; 2002 May; 15(4):233-237. PubMed ID: 12677207
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Increased permeability of the blood-brain barrier in lymphostatic encephalopathy.
    Várkonyi T; Joó F; Csillik B; Zoltán OT; Földi M
    Angiologica; 1969; 6(5):275-9. PubMed ID: 5344347
    [No Abstract]   [Full Text] [Related]  

  • 109. Blood-brain barrier permeability during hyperthermia.
    Shivers RR; Wijsman JA
    Prog Brain Res; 1998; 115():413-24. PubMed ID: 9632944
    [No Abstract]   [Full Text] [Related]  

  • 110. TNF-alpha in trauma patients: a touch is just enough.
    Pellegrin K; Peterson VM; Vadgama J; Wu Y; Fleming AW
    Curr Surg; 2000 Nov; 57(6):638. PubMed ID: 11120320
    [No Abstract]   [Full Text] [Related]  

  • 111. TNF homes in on tumor vessels.
    Nat Biotechnol; 2000 Nov; 18(11):1131. PubMed ID: 11062415
    [No Abstract]   [Full Text] [Related]  

  • 112. Reduction of acute radiation-induced brain injury in rats by anlotinib.
    Xiong Y; Zhou X; Yu C; Tong Y
    Neuroreport; 2024 Feb; 35(2):90-97. PubMed ID: 38109375
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Toll-like Receptors as Pro-Thrombotic Drivers in Viral Infections: A Narrative Review.
    Panzer B; Kopp CW; Neumayer C; Koppensteiner R; Jozkowicz A; Poledniczek M; Gremmel T; Jilma B; Wadowski PP
    Cells; 2023 Jul; 12(14):. PubMed ID: 37508529
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Natural product-based bioactive agents in combination attenuate neuroinflammation in a tri-culture model.
    Liu Y; Chang D; Liu T; Zhou X
    Front Pharmacol; 2023; 14():1135934. PubMed ID: 36873986
    [No Abstract]   [Full Text] [Related]  

  • 115. Reversible Splenial Lesion Syndrome (RESLES) after Nitrous Oxide Abuse: A Case Report.
    Tao Y; Han J; Jian X; Li Y
    Brain Sci; 2022 Sep; 12(10):. PubMed ID: 36291218
    [TBL] [Abstract][Full Text] [Related]  

  • 116. The role of diphenhydramine HCl on tumor necrosis factor-α levels in wistar rats with traumatic brain injury: An in vivo study.
    Kurniawan VR; Islam AA; Adhimarta W; Zainuddin AA; Widodo D; Nasrullah ; Ihwan A; Wahyudi ; Faruk M
    Ann Med Surg (Lond); 2022 Sep; 81():104399. PubMed ID: 36147062
    [TBL] [Abstract][Full Text] [Related]  

  • 117. An Overview of The Role of Tumor Necrosis Factor-Alpha in Epileptogenesis and Its Terapeutic Implications.
    Michev A; Orsini A; Santi V; Bassanese F; Veraldi D; Brambilla I; Marseglia GL; Savasta S; Foiadelli T
    Acta Biomed; 2022 Mar; 92(S4):e2021418. PubMed ID: 35441606
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Targeting Inflammatory Mediators in Epilepsy: A Systematic Review of Its Molecular Basis and Clinical Applications.
    Costagliola G; Depietri G; Michev A; Riva A; Foiadelli T; Savasta S; Bonuccelli A; Peroni D; Consolini R; Marseglia GL; Orsini A; Striano P
    Front Neurol; 2022; 13():741244. PubMed ID: 35359659
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Neurotoxicity of Tumor Immunotherapy: The Emergence of Clinical Attention.
    Zhang B; Li X; Yin T; Qin D; Chen Y; Ma Q; Shu P; Wang Y
    J Oncol; 2022; 2022():4259205. PubMed ID: 35087588
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Modulating neuroinflammation in neurodegeneration-related dementia: can microglial toll-like receptors pull the plug?
    Tiwari RK; Moin A; Rizvi SMD; Shahid SMA; Bajpai P
    Metab Brain Dis; 2021 Jun; 36(5):829-847. PubMed ID: 33704660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.